For the Inventor, By the Inventor

Enter assignee name

Cham, Switzerland

Galderma S.a.

Calculating rank

USPTO Granted Patents = 86

% Expired Patents = 44.2

CIPO Patents = 5

EPO Patents = 76

Trademarks = 22

Forward Citations = 288

Loading Chart...

Loading Chart...

82 inventors (with patents filed for the assignee):

Philippe Andres (10 out of 14 patents)

Alexandre Kaoukhov (9 out of 9 patents)

Jean Jacovella (8 out of 10 patents)

4. Claire Mallard (8 out of 33 patents)

5. Laurent Chantalat (8 out of 18 patents)

6. Vincent Manetta (7 out of 8 patents)

7. Gary R Watkins (7 out of 8 patents)

8. Jean-Paul Chappuis (6 out of 6 patents)

9. Nathalie Willcox (6 out of 17 patents)

10. Jeffrey D Parks (6 out of 6 patents)

11. L Dean Parks (6 out of 15 patents)

12. Sandrine Segura-Orsoni (6 out of 7 patents)

13. Jerry Roth (6 out of 8 patents)

14. Nancy Puglia (6 out of 7 patents)

15. Rosario Ramirez (6 out of 7 patents)

Core Competencies:

Avermectin

Acne Treatment

Indigo Naturalis

Rosacea

Hyaluronic Acid

Skin Care

Dermatological Creams

Topical Applications

Pharmaceutical Compositions

Anti-Inflammatory

Hair Loss

Ophthalmic Pathologies

86 patents: Sort by Forward Citations

1. 11116811 - Pharmaceutical composition comprising refined indigo naturalis extracts and the use thereof (2021-09-14),

2. 10899894 - Method for preparing acylated crosslinked glycosaminoglycans (2021-01-26),

3. 10857306 - Syringe (2020-12-08),

4. 10849854 - Process for preparing a composition comprising a high concentration of one or more avermectins (2020-12-01),

5. 10745493 - Graft copolymer (2020-08-18),

6. 10695391 - Extract from Indigo Naturalis and a process for preparing the same (2020-06-30),

7. 10688117 - Topical wash composition for use in acne patients (2020-06-23),

8. 10668120 - Antibacterial indigo naturalis or indigo-producing plant extract and use thereof (2020-06-02),

9. 10653659 - Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne (2020-05-19),

10. 10610594 - BPO wash gel composition (2020-04-07),

11. 10555985 - Pharmaceutical composition comprising refinedextracts and the use thereof (2020-02-11),

12. 10533061 - Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid and uses thereof (2020-01-14),

13. 10463643 - Composition comprising a compound from the family of avermectins and doxycycline for the treatment of rosacea (2019-11-05),

14. 10398720 - Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis (2019-09-03),

15. 10376492 - Use of a macrocyclic lactone for treating a complication from a papilloma virus infection (2019-08-13),

Company Overview

Galderma S.a., headquartered in Cham, Switzerland, specializes in dermatological compositions aimed at enhancing skin health and appearance. The company focuses on developing innovative treatments for various skin conditions, including acne and rosacea, utilizing advanced technologies such as Avermectin and Hyaluronic Acid. Galderma's product portfolio includes topical applications and dermatological creams that cater to diverse skincare needs, reinforcing its commitment to improving patient outcomes in dermatology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

86 Patents

#2 in Cham

#185 in Switzerland

#8,885 in the World

Cham, Switzerland

Galderma S.a.

Forward Citations = 288

82 inventors:

Philippe Andres (10 out of 14 patents)

Alexandre Kaoukhov (9 out of 9 patents)

Jean Jacovella (8 out of 10 patents)

4. Claire Mallard (8 out of 33 patents)

5. Laurent Chantalat (8 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galderma S.a.. Retrieved from https://idiyas.com/company/galderma-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…